DEF 14A Filing

Company

Matinas BioPharma Holdings, Inc.

Filed

March 3, 2025

Period of Report

March 3, 2025

Accession Number

0001493152-25-008921

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →